Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer

NCT06587789 · clinicaltrials.gov ↗
RECRUITING
Status
286
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators